These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2248149)
1. The dilemma of manifesting carriers in the context of myoblast transplantation. Kunkel LM Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149 [No Abstract] [Full Text] [Related]
2. The principles and practice of myoblast transfer. Karpati G Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156 [No Abstract] [Full Text] [Related]
4. Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy. Lupski JR; Garcia CA; Zoghbi HY; Hoffman EP; Fenwick RG Am J Med Genet; 1991 Sep; 40(3):354-64. PubMed ID: 1683155 [TBL] [Abstract][Full Text] [Related]
5. Genetic and biochemical determinations in the pre-transplant workup and in the post-transplant assessment period. Worton RG; Bulman DE; Zubrzycka-Gaarn EE; Ray PN Adv Exp Med Biol; 1990; 280():219-25; discussion 225-6. PubMed ID: 2248141 [No Abstract] [Full Text] [Related]
6. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers. Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326 [TBL] [Abstract][Full Text] [Related]
7. Additional case of female monozygotic twins discordant for the clinical manifestations of Duchenne muscular dystrophy due to opposite X-chromosome inactivation. Abbadi N; Philippe C; Chery M; Gilgenkrantz H; Tome F; Collin H; Theau D; Recan D; Broux O; Fardeau M Am J Med Genet; 1994 Aug; 52(2):198-206. PubMed ID: 7802009 [TBL] [Abstract][Full Text] [Related]
8. Myoblast transfer in muscular dystrophy: panacea or pie in the sky? Dubowitz V Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179 [No Abstract] [Full Text] [Related]
9. Do twin Lyons have larger spots? Nance WE Am J Hum Genet; 1990 Apr; 46(4):646-8. PubMed ID: 2316517 [No Abstract] [Full Text] [Related]
10. The role of the xmd dog in the assessment of myoblast transfer therapy. Cooper BJ Adv Exp Med Biol; 1990; 280():279-82; discussion 282-4. PubMed ID: 2248148 [No Abstract] [Full Text] [Related]
11. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125 [TBL] [Abstract][Full Text] [Related]
12. In situ hybridization shows direct evidence of skewed X inactivation in one of monozygotic twin females manifesting Duchenne muscular dystrophy. Zneimer SM; Schneider NR; Richards CS Am J Med Genet; 1993 Mar; 45(5):601-5. PubMed ID: 8456832 [TBL] [Abstract][Full Text] [Related]
14. Anomalous X chromosome inactivation: the link between female zygotes, monozygotic twinning, and neural tube defects? J Med Genet; 1988 Mar; 25(3):213-6. PubMed ID: 3351914 [No Abstract] [Full Text] [Related]
15. Myoblast transplantation in inherited myopathies. Morgan JE; Watt DJ Mol Cell Biol Hum Dis Ser; 1993; 3():303-31. PubMed ID: 8111544 [No Abstract] [Full Text] [Related]
16. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042 [TBL] [Abstract][Full Text] [Related]